INGESTEM includes:

• 
• 
  ajp70791
• 
• 

• Four iPSC production platforms (ESTeam, I-Stem, PrimaStem, SAFE-IPS)
• Four  tissue bioengineering platforms (ESTeam, I-Stem, IGBMC, SAFE-IPS)
• Two high-throughput screening platforms (I-Stem, IGBMC)
• One transgenic platform (PrimaStem)
• Two production platforms of future Advanced-Therapy Medicinal Products (ATMPs) for clinical trials phase I-II (ESTeam, I-Stem)

All of these platforms work in a coordinated manner according to their expertise and the organizational scheme as below.